Notice2024-05772
Notice of Award of a Sole Source Cooperative Agreement To Fund National Tuberculosis Control Program (NTCP)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 19, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award(s) of approximately $3,000,000, for Year 1 funding to NTCP. The award will improve the capacity of the health system at national, regional, district, and facility levels to provide an effective public health response for Tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection in Cameroon, reduce disease burden, and contribute to achieving and sustaining epidemic control. Funding amounts for years 2-5 will be set at continuation.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 54 (Tuesday, March 19, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 54 (Tuesday, March 19, 2024)]
[Notices]
[Page 19593]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-05772]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Sole Source Cooperative Agreement To Fund
National Tuberculosis Control Program (NTCP)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award(s) of approximately $3,000,000, for Year 1 funding to NTCP. The
award will improve the capacity of the health system at national,
regional, district, and facility levels to provide an effective public
health response for Tuberculosis (TB) and human immunodeficiency virus
(HIV) co-infection in Cameroon, reduce disease burden, and contribute
to achieving and sustaining epidemic control. Funding amounts for years
2-5 will be set at continuation.
DATES: The period for this award will be September 30, 2024, through
September 29, 2029.
FOR FURTHER INFORMATION CONTACT: F.E. Harrison, Center for Global
Health, Centers for Disease Control and Prevention, telephone: (404)
639-6095, email: <a href="/cdn-cgi/l/email-protection#4320283570032027206d242c35"><span class="__cf_email__" data-cfemail="b7d4dcc184f7d4d3d499d0d8c1">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: This sole source award will accelerate
progress in reducing the burden of TB and TB/HIV co-infection in
Cameroon through a multistakeholder approach.
NTCP is in a unique position to conduct this work, as it is the
only institution that has the legal mandate to develop and implement
the national strategic plan for TB control, which aims to reduce the
morbidity and mortality associated with TB.
Summary of the Award
Recipient: National Tuberculosis Control Program (NTCP).
Purpose of the Award: The purpose of this award is to improve the
capacity of the health system at national, regional, district, and
facility levels to provide an effective public health response for TB
and HIV co-infection in Cameroon, reduce disease burden, and contribute
to achieving and sustaining epidemic control.
Amount of Award: For NTCP, the approximate year 1 funding amount
will be $3,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to
the availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003) (22 U.S.C. 7601, et seq.) and Public Law 110-293 (the Tom
Lantos and Henry J. Hyde United States Global Leadership Against HIV/
AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008), and
Public Law 113-56 (PEPFAR Stewardship and Oversight Act of 2013).
Period of Performance: The period for this award will be September
30, 2024, through September 29, 2029.
Dated: March 13, 2024.
Jamie Legier,
Acting Director, Office of Grants Services, Centers for Disease Control
and Prevention.
[FR Doc. 2024-05772 Filed 3-18-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 19, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.